Abstract. Since cloning of the T-type or Ca V 3.n calcium channel family in [1998][1999] 
T-type or low-voltage-activated or according to the most recent classification Ca V 3 channels (Ertel et al. 2000) are distinguished by their negative voltage threshold for activation, which is between -70 mV and -60 mV. Such a low activation threshold allows them to participate together with sodium channels in initiation of action potential generation or even generate so-called low threshold action potentials in the absence of sodium channels. Ca V 3 channels play a role in pathologies including hypertension, heart failure, sleep disorders, epilepsy, drug addiction and neuropathic pain. Currently, three representatives of this channel class are known: Ca V 3.1, Ca V 3.2 and Ca V 3.3. Ca V 3.1 and Ca V 3.2 channels are ubiquitously expressed. The Ca V 3.2 was found in brain, peripheral nervous tissue (dorsal root ganglion, autonomic ganglia), heart (myocytes, pacemaker cells), smooth muscle, skeletal muscle, bone (osteoblasts), endocrine cells (adrenal, pituitary, pancreas, thyroid) and in sperm. The Ca V 3.1 was found in all mentioned tissues except for skeletal muscle. Expression of the Ca V 3.3 channels is restricted to the brain and peripheral nervous tissue (for references see Iftinca and Zamponi 2009) .
Detail understanding of mechanisms underlying their regulation may greatly facilitate development of new therapies. Metal ions represent a preferred tool for the mapping of a permeation pathway and for the description of voltage sensor activation. L-type calcium channel blockers dihydropyridines (DHP) and phenylalkylamines (PAA) are widely used for treatment of cardiovascular diseases therefore their potential ability to regulate T-type calcium channels is of major interest. This review concentrates predominantly on facts reported since the last review (Lacinova 2004) .
Metal ions

Divalent metal cations (M 2+ )
Divalent metal cations are commonly known blockers of both high-and low-voltage-activated calcium channels (VACC) lacking high degree of selectivity for a specific VACC class. Cd 2+ fully blocks high-VACC in concentrations 5-50 μM ( Fox et al. 1987; Lacampagne et al. 1994; Bleakman et al. 1995) . Millimolar concentration of Co 2+ is necessary for complete block of high-VACC (Wakamori et al. 1998; Fan and Palade 1999) . Compare to high-VACC Co 2+ is more effective and Cd 2+ less effective in blocking Ca V 3 channels with IC 50 s in hundreds of µM (Diaz et al. 2005) . Ca V 3.2 channels are approximately 3-fold more sensitive than the Ca V 3.1 and Ca V 3.3 channels (see Table 1 ). Consistent with an occlusion of the channel's conductive pore the inward currents were strongly blocked while outward current were only moderately affected by Co 2+ and Cd 2+ (Diaz et al. 2005 Table 1 ). These three ions are distinguished by 10-20-fold higher efficiency of Ca V 3.2 channel inhibition (Table 1) . Zn 2+ and Cu 2+ are nutritional elements with physiological significance. They are present in moderate concentration in human plasma but may occur in high concentration in brain (Mathie et al. 2006; Richelle et al. 2006) . Both Zn 2+ and Cu 2+ are essential divalent cations involved in regulation of several cellular processes including neuronal excitability, synaptic plasticity, gene expression and enzymatic reactions. Zinc blocks VACC in order of efficiency Ca V 1.2 > Ca V 3.2 > Ca V 2.3 > Ca V 2.2 = Ca V 2.1 ≥ Ca V 3.3 = Ca V 3.1 (Sun et al. 2007 ). Study published along with Sun's report confirmed relative selectivity of Zn 2+ ions for Ca V 3.2 channels compare to Ca V 3.1 and Ca V 3.3 channels (Traboulsie et al. 2007 ). It was explained by Nelson and coauthors (Nelson et al. 2007b ) who have shown that Zn 2+ constitutively inhibits the Ca V 3.2 channel via an interaction site involving histidine H191 in extracellular loop connecting IS3-IS4 segments, i.e., within the putative voltage sensor of the channel. Ca V 3.1 and Ca V 3.3 channels have a glutamine at corresponding position. Binding pocket for Zn 2+ on Ca V 3.2 channel was further refined by Kang and coauthors that identified D189-G190-H191 in IS3-IS4 loop and D122 in IS2 helix as its main constituents (Kang et al. 2010) . As zinc is a common contaminant of experimental solutions this finding has an important implication for experiments on Ca V 3 channels in general. Inhibition of the Ca V 3.2 channel can be relieved by zinc-chelating agents including L-cysteine, dithiotreitol, bovine serum albumin, diethylenetriaminepentaacetic acid and N,N,N' ,N'-tetra-2-picolylethylenediamine. Relief of the inhibition lowers the threshold for nociceptor excitability both in vitro and in vivo and represents novel mechanism of nociceptor sensitization (Nelson et al. 2007b) . Finding that modulation of the Ca V 3 channels increased the frequency and the duration of thalamocortical firing (Cataldi et al. 2007; Noh et al. 2010a) implies that endogenous Zn 2+ may have a role in controlling thalamocortical oscillations as well.
Binding pocket defined by histidine H191 underlies also relative selectivity of Cu 2+ (Nelson et al. 2007a ) and Ni 2+ (Kang et al. 2010) for Ca V 3.2 over Ca V 3.1 and Ca V 3.3 channels. This high-affinity site specific to the Ca V 3.2 channel is located within voltage sensor of the channel domain I. Zn 2+ , Cu 2+ and Ni 2+ inhibit the current via high-affinity site by stabilizing closed state of the channel. This interaction does not alter kinetics or voltage dependence of current activation, inactivation and deactivation.
Interaction with the second low-affinity site located inside the conductive pore modulates the current through Ca V 3.1 and Ca V 3.3 channels in a complex manner. Nickel positively shifts voltage dependence of activation and accelerates deactivation of the Ca V 3.1 channel (Lacinova et al. 2000) . Zinc negatively shifts voltage dependencies of activation and inactivation and slows inactivation kinetics of Ca V 3.1 and Ca V 3.3 channels (Traboulsie et al. 2007 ). Further, it slows dramatically deactivation of the Ca V 3.3 channel (Traboulsie et al. 2007 ) and moderately slows deactivation of the Ca V 3.1 channel (Noh et al. 2010b ). None of these effects was observed on Ca V 3.2 channels (Traboulsie et al. 2007) most probably because at zinc concentration necessary for their occurrence the channel is already fully blocked via high affinity site located on the voltage sensor.
Trivalent metal cations (M 3+ )
Analysis of gating current reflecting activation of voltage sensor of a channel supplies information on basic regulatory mechanisms. Necessary pre-requisition is complete inhibition of ion current by a blocker which blocks the channel conducting pore without affecting movement of voltage sensor of the channel itself. Beedle et al. 2002) . They act solely by entering and occluding the conductive pore of the channel. All currently known features of Ca V 3 channels inhibition by M 3+ can be interpreted in accord with this mechanism: 1) consistent with an open channel block inhibition of inward current amplitude by M 3+ was largely voltageindependent within physiological range of membrane depolarizations (Mlinar and Enyeart 1993; Beedle et al. 2002; Obejero-Paz et al. 2004) ; 2) M 3+ did not alter kinetic of inward current trace (Mlinar and Enyeart 1993; Beedle et al. 2002; Lacinova et al. 2002) and such alteration is considered a signature of an inactivated channel's inhibition; 3) inhibitory potency of M 3+ decreases when concentration of charge carrier increases (Beedle et al. 2002) (Mlinar and Enyeart 1993; Beedle et al. 2002) consistent with more difficult entry of bigger ions into conducting pore.
Dihydropyridines and phenylalkylamines
DHP were thought to selectively interact with L-type calcium channels (Tsien et al. 1988; Hess 1990; Triggle 2007) , however, more recently their interaction with voltage-dependent potassium channels was reported ( Lin et al. 2001; Gao et al. 2005; Caro et al. 2011) . They were developed and are still widely used for a treatment of cardiovascular disorders. PAA are clinically used as L-type calcium channels, nevertheless, they interact with potassium ion channels, too (Lefevre et al. 1991; Robe and Grissmer 2000; Rybalchenko et al. 2001) .
Initially, T-type calcium channels were described as DHPinsensitive. Nevertheless, during recent years several authors reported block of Ca V 3 channels by DHPs in micromolar or even nanomolar concentrations (Table 1) . Nimodipine and isradipine blocked the Ca V 3.1 channel with an IC 50 below 10 µM (Drigelova et al. 2009 ). This value is more than two decimal orders higher than the IC 50 = 16 nM reported for the Ca V 1.2 channel at a HP = -80 mV (Schuster et al. 1996) . Furukawa and collaborators (Furukawa et al. 2005) demonstrated that amlodipine, barnidipine, manidipine and nicardipine inhibit with similar efficiency T-type (Ca V 3.1) and L-type (Ca V 1.2) calcium channels expressed in Xenopus oocytes. In the same model, benidipine and efonidipe were even slightly more effective in blocking T-type than L-type calcium channels with IC 50 s close to 10 µM (Furukawa et al. 2005) .
More detailed analysis demonstrated strong voltage-and isomer-dependency of the inhibition of the Ca V 3.1 channel by efonidipine (Furukawa et al. 2004) . In mammalian BHK cells R(-) efonidipine blocked Ca V 3.1 channels at a holding potential (HP) -100 mV with an IC 50 about 10 µM and at a HP -60 mV with an IC 50 about 0.1 µM. S(+) enantiomer had similar effect on both channels at both HPs (Furukawa et al. 2004 ). More effective was efonidipine in inhibition of the Ca V 3.2 channel in HEK 293 cells with an IC 50 of 240 nM at a HP -90 mV (Inayoshi et al. 2011) . Benidipine blocked the Ca V 3.2 channel expressed in HEK 293 cells with an IC 50 140 nM (Inayoshi et al. 2011) . (S, S) benidipine was slightly better blocker (IC 50 = 40 nM) than (R, R) benidipine (IC 50 = 146 nM) (Inayoshi et al. 2011) .
Perez-Reyes and coauthors (Perez-Reyes et al. 2009 ) analyzed inhibition of the calcium transport through the Ca V 3.2 channels expressed in HEK 293 cells by variety of DHPs. Efonidipine, felodipine, isradipine and niguldipine appeared to be potent T-type channel blockers with IC 50 s < 3 µM while amlodipine and nifedipine were less efficient with IC 50 s 31 µM and 21 µM, respectively (PerezReyes et al. 2009 ).
The most efficient Ca V 3 channel blockers efonidipine and benidipine do block also L-type calcium channels. Furukawa and coauthors (Furukawa et al. 2004 ) called efonidipine selective T-type calcium channel blocker as they found an IC 50 for the Ca V 1.2 channel in millimolar region. However, more recently Tanaka and coauthors (Tanaka et al. 2010) reported the half-maximal inhibitory concentration for the Ca V 1.2 channels around 1 µM, i.e., comparable with the IC 50 for the Ca V 3.2 channel (Perez-Reyes et al. 2009 ) and the Ca V 3.1 channel (Furukawa et al. 2004) . Further, in mouse ventricular cardiomyocytes efonidipine half-maximal block of both L-type and T-type calcium currents required the same concentration of efonidipine 10 µM (Horiba et al. 2008) . Even considering that in such preparation identity of individual VACC cannot be equivocally distinguished this finding questions suggested selectivity of efonidipine for T-type calcium channels.
Benidipine seems to be more selective T-type calcium channel blocker as the half-maximal blocking concentration for the Ca V 1.2 channel was 14 µM (Furukawa et al. 1999) , i.e., 100-fold higher than the half-maximal inhibitory concentration for the Ca V 3.2 channel (Inayoshi et al. 2011 ). Still such claim should be taken with certain caution as the former was measured in Xenopus oocytes while the later was measured in mammalian (HEK 293) cell line.
Most commonly used PAA verapamil was previously shown to block T-type calcium channels in smooth muscle cells with an IC 50 = 30 µM (Kuga et al. 1990 ) and in spermatogenic cells with an IC 50 = 70 µM (Arnoult et al. 1998) . In mammalian expression system verapamil inhibited the Ca V 3.1 channel with an IC 50 = 21 µM at a HP of -130 mV and with an IC 50 = 5 µM at a HP of -70 mV (Freeze et al. 2006 ). The later is close to values 3-8 µM reported for recombinantly expressed Ca V 1.2 channel (Lacinova et al. 1995; Johnson et al. 1996) and for Ca V 1.2 channel in cardiac myocytes (Wegener and Nawrath 1995) . Charged 4-desmethoxyverapamil (D888) blocked the recombinant Ca V 3.1 with virtually the same efficiency as neutral verapamil with an IC 50 less than 20 µM (Bergson et al. 2011) . D888 is almost thousand-fold more effective L-type calcium channels blocker. An IC 50 reported for recombinant Ca V 1.2 channels is 50 nM (Hockerman et al. 1995; Johnson et al. 1996) .
Conclusion
Block of VACC by metal cations was traditionally viewed as simple physical occlusion of the channel's conducting pore. High affinity interaction with the binding pocket located at extracellular part of the voltage sensor is a novel mechanism. It is notable, that the later does not influence voltage dependence or kinetics of the current while the former may modulate the current kinetics and/or voltage dependence in a complex manner. DHPs and PAAs were widely used in clinical practice as L-type calcium channel blockers. Now it is becoming clear that several of them can block T-type calcium channels at clinically relevant concentrations.
